Anticancer Miliusane Derivatives (Granted)

Hongjie ZHANG

Anticancer Miliusane Derivatives (Granted)

Chinese Medicine - Teaching and Research Division

Research output: Patent

Original language	English
Patent number	9,822,071
IPC	A61-ZH-Mili-US03
Priority date	5/06/12
Filing date	1/06/17
Publication status	Published - 21 Sept 2017

User-Defined Keywords

Biotechnology
Breast cancer
Cancer
Colon cancer
Compound
Drug
Lung cancer
Medicine
Melanoma cancer
Miliusane
Oral epidermoid cancer
Prostate Cancer
bio_cell
bio_intestine
bio_lung
bio_prostate
bio_skin

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@misc{d4ebc9ac117c4e6a9b2ed2cf8d5b44fe,

title = "Anticancer Miliusane Derivatives (Granted)",

keywords = "Biotechnology, Breast cancer, Cancer, Colon cancer, Compound, Drug, Lung cancer, Medicine, Melanoma cancer, Miliusane, Oral epidermoid cancer, Prostate Cancer, bio_cell, bio_intestine, bio_lung, bio_prostate, bio_skin",

author = "Hongjie ZHANG",

year = "2017",

month = sep,

day = "21",

language = "English",

type = "Patent",

note = "9,822,071; A61-ZH-Mili-US03",

}

TY - PAT

T1 - Anticancer Miliusane Derivatives (Granted)

AU - ZHANG, Hongjie

PY - 2017/9/21

Y1 - 2017/9/21

KW - Biotechnology

KW - Breast cancer

KW - Cancer

KW - Colon cancer

KW - Compound

KW - Drug

KW - Lung cancer

KW - Medicine

KW - Melanoma cancer

KW - Miliusane

KW - Oral epidermoid cancer

KW - Prostate Cancer

KW - bio_cell

KW - bio_intestine

KW - bio_lung

KW - bio_prostate

KW - bio_skin

M3 - Patent

M1 - 9,822,071

Y2 - 2017/06/01

ER -